WithdrawnPhase 4NCT02915042
Dexmedetomidine vs Placebo for Pediatric Cleft Palate Repair
Studying Cleft palate
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Baylor College of Medicine
- Principal Investigator
- Chris D. Glover, MDBaylor College of Medicine - Texas Children's Hospital
- Intervention
- Dexmedetomidine(drug)
- Eligibility
- 12 years · All sexes
- Timeline
- 2017 – 2019
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02915042 on ClinicalTrials.govOther trials for Cleft palate
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07048418Aesthetic and Functional Self-Assessment Following Rhinoseptoplasty in Patients With Unilateral Cleft Lip and PalateUniversity Hospital, Montpellier
- RECRUITINGPHASE4NCT06962306Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate SurgeryDuke University
- RECRUITINGNCT06895395High and Low Intensity Speech Intervention in Children With a Cleft Palate: Perceptions of Children, Their Caregivers and Speech-language PathologistsUniversity Ghent
- RECRUITINGNCT06856330Effect of Furlow Palatoplasty With Buccal Myomucosal Flap on the Speech DevelopmentFayoum University
- RECRUITINGNANCT05492266Expiratory Muscle Strength Training for Hypernasal Speech in ChildrenNoel Jabbour
- RECRUITINGNCT06905678The Financial and Emotional Impact of Cleft PalateUniversity Hospital, Ghent
- RECRUITINGNANCT06381713Effect and Cost-utility of of High Intensity vs. Low Intensity Speech Intervention in Children With Cleft PalateUniversity Ghent
- RECRUITINGNANCT06420336QL vs LAI for PalatoplastyMedical University of South Carolina